{
    "nctId": "NCT00559858",
    "briefTitle": "Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer",
    "officialTitle": "A Randomised Placebo-controlled Study Evaluating the Role of Pyridoxine in Controlling Capecitabine-induced Hand-foot Syndrome",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Colorectal Cancer, Palmar-plantar Erythrodysesthesia",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 270,
    "primaryOutcomeMeasure": "Incidence of capecitabine dose modifications (dose delay and dose reductions) due to toxicity",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of advanced colorectal or breast carcinoma\n\n  * Hormone receptor status not specified\n* Receiving single-agent capecitabine chemotherapy\n* Measurable disease for response assessment, determined on an individual patient basis, using conventional clinical and/or radiological methods\n\nPATIENT CHARACTERISTICS:\n\n* ECOG performance status 0-2\n* Menopausal status not specified\n* Life expectancy \u2265 12 weeks\n* Hemoglobin \u2265 10 g/dL\n* Platelet count \u2265 100,000 mm\\^3\n* WBC \u2265 3,000/mm\\^3\n* ANC \u2265 1,500/mm\\^3\n* Bilirubin \u2264 1.3 x upper limit of normal (ULN)\n* Alkaline phosphatase \u2264 5 x ULN\n* AST and ALT \u2264 5 x ULN\n* Creatinine \u2264 1.5 x ULN\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception during and for 3 months after completion of study treatment\n* No other serious or uncontrolled illness which, in the opinion of the investigator, makes it undesirable for the patient to enter the trial\n* No medical or psychiatric condition which would influence the ability to provide informed consent\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* At least 6 weeks since prior investigational agents\n* Concurrent radiotherapy allowed\n* No other concurrent chemotherapy or immunotherapy\n* No concurrent nonsteroidal anti-inflammatory drugs NSAIDs) for the primary purpose of treating hand-foot syndrome (HFS) or cancer\n\n  * NSAIDs for conditions other than HFS or cancer allowed",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}